CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: ethionamide
Accession: CHEBI:4885
browse the term
Definition: A thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide.
Synonyms: exact_synonym: 2-ethylpyridine-4-carbothioamide
related_synonym: 2-ethyl-4-thiopyridylamide; ETH; ETP; Ethinamide; Ethioniamide; Ethylisothiamide; Ethyonomide; Etionamid; Etionamide; Etioniamid; Formula=C8H10N2S; InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11); InChIKey=AEOCXXJPGCBFJA-UHFFFAOYSA-N; SMILES=CCc1cc(ccn1)C(N)=S; Trecator; ethionamidum; etionamida
xref: Beilstein:116474; CAS:536-33-4; DrugBank:DB00609; Drug_Central:1083; HMDB:HMDB0014747; KEGG:C07665; KEGG:D00591; LINCS:LSM-5620
xref_mesh: MESH:D005000
xref: PMID:14651620; PMID:15673755; PMID:15850780; Patent:GB800250; Reaxys:116474; Wikipedia:Ethionamide
G
ACE2
angiotensin converting enzyme 2
decreases expression
EXP
Ethionamide results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:15,518,197...15,607,211
Ensembl chr X:15,494,566...15,607,236
G
CCL2
C-C motif chemokine ligand 2
increases expression
ISO
Ethionamide results in increased expression of CCL2 mRNA; Ethionamide results in increased expression of CCL2 protein
CTD
PMID:25051504
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL5
C-C motif chemokine ligand 5
affects expression
ISO
Ethionamide affects the expression of CCL5 protein
CTD
PMID:25051504
NCBI chr17:35,871,491...35,880,360
Ensembl chr17:35,871,491...35,880,793
G
CXCL10
C-X-C motif chemokine ligand 10
decreases expression
ISO
Ethionamide results in decreased expression of CXCL10 protein
CTD
PMID:25051504
NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
G
FMO2
flavin containing dimethylaniline monoxygenase 2
increases oxidation
EXP
FMO2 protein results in increased oxidation of Ethionamide
CTD
PMID:26062974
NCBI chr 1:171,185,208...171,212,686
Ensembl chr 1:171,185,249...171,212,686
G
GCLM
glutamate-cysteine ligase modifier subunit
multiple interactions
EXP
Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of GCLM mRNA]
CTD
PMID:26708503
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
G
HMOX1
heme oxygenase 1
multiple interactions
EXP
Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of HMOX1 mRNA]
CTD
PMID:26708503
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
IL10
interleukin 10
decreases expression
ISO
Ethionamide results in decreased expression of IL10 protein
CTD
PMID:25051504
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12B
interleukin 12B
increases expression
ISO
Ethionamide results in increased expression of IL12B protein
CTD
PMID:25051504
NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
G
IL1A
interleukin 1 alpha
increases expression
ISO
Ethionamide results in increased expression of IL1A protein
CTD
PMID:25051504
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
increases expression affects expression
ISO
Ethionamide results in increased expression of IL1B mRNA Ethionamide affects the expression of IL1B protein
CTD
PMID:25051504
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL6
interleukin 6
decreases expression
ISO
Ethionamide results in decreased expression of IL6 protein
CTD
PMID:25051504
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
KEAP1
kelch like ECH associated protein 1
multiple interactions
EXP
KEAP1 mRNA inhibits the reaction [Ethionamide results in increased susceptibility to arsenic trioxide]
CTD
PMID:26708503
NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
G
LEP
leptin
decreases expression
ISO
Ethionamide results in decreased expression of LEP protein
CTD
PMID:25051504
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
G
NFE2L2
NFE2 like bZIP transcription factor 2
multiple interactions
EXP
NFE2L2 mRNA promotes the reaction [Ethionamide results in increased susceptibility to arsenic trioxide]
CTD
PMID:26708503
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
G
SRXN1
sulfiredoxin 1
multiple interactions
EXP
Ethionamide inhibits the reaction [arsenic trioxide results in increased expression of SRXN1 mRNA]
CTD
PMID:26708503
NCBI chr20:646,615...653,200
Ensembl chr20:646,615...653,200
G
TNF
tumor necrosis factor
increases expression
ISO
Ethionamide results in increased expression of TNF protein
CTD
PMID:25051504
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
VEGFA
vascular endothelial growth factor A
increases expression
ISO
Ethionamide results in increased expression of VEGFA protein
CTD
PMID:25051504
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all